MD

Value 202020212022202320242025 TTM Total revenue 1.73 B1.91 B1.97 B1.99 B2.01 B1.91 B 1.91 B Gross profit 1.73 B1.91 B1.97 B1.99 B2.01 B1.91 B 1.91 B Operating expenses 1.64 B1.71 B1.8 B1.99 B2.08 B1.71 B 1.71 B Selling/general/admin expenses 248.95 M263.36 M231.4 M227.54 M238.44 M240.79 M 240.79 M Research & development —————— — Operating income 98.13 M202.92 M172.69 M7.32 M-68.71 M208.81 M 208.81 M Non-Operating Income, Total -90.98 M-67.69 M-91.32 M-55.68 M-32.63 M7.62 M 7.62 M Interest expense, net of interest capitalized 110.48 M68.72 M39.7 M42.08 M40.74 M35.97 M 35.97 M Non-Operating Income, excl. Interest Expenses -201.47 M-136.41 M-131.01 M-97.75 M-73.37 M-28.35 M -28.35 M Unusual income/expense —————— — Pretax income 7.15 M135.23 M81.37 M-48.36 M-101.34 M216.43 M 216.43 M Equity in earnings 1.58 M1.91 M1.72 M2.06 M2.34 M3.63 M 3.63 M Taxes 16.73 M27.24 M18.81 M12.05 M-2.27 M51.04 M 51.04 M Non-controlling/minority interest —27 K-4 00000— — After tax other income/expense 198 K2.35 M-144 K3.17 M2.97 M4.56 M 4.56 M Net income before discontinued operations -9.58 M108.01 M62.57 M-60.41 M-99.07 M165.39 M 165.39 M Discontinued operations -786.91 M22.95 M3.77 M00— — Net income -796.49 M130.96 M66.33 M-60.41 M-99.07 M165.39 M 165.39 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -796.49 M130.96 M66.33 M-60.41 M-99.07 M165.39 M 165.39 M Basic earnings per share (Basic EPS) -9.551.540.790.73-1.191.97 1.97 Diluted earnings per share (Diluted EPS) -9.551.530.790.73-1.191.94 1.94 Average basic shares outstanding 83.39 M84.83 M83.47 M82.2 M83.33 M84.08 M 337.92 M Diluted shares outstanding 83.39 M85.83 M84.12 M82.2 M83.33 M85.27 M 341.84 M EBITDA 126.57 M235.06 M208.32 M43.49 M-36.49 M230.64 M 230.64 M EBIT 98.13 M202.92 M172.69 M7.32 M-68.71 M208.81 M 208.81 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 28.44 M32.15 M35.64 M36.17 M32.23 M21.83 M 21.83 M